Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).
Brunkow, M.E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68–73 (2001).
Wildin, R.S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18–20 (2001).
Kim, J.M., Rasmussen, J.P. & Rudensky, A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191–197 (2007).
Tang, Q. & Bluestone, J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9, 239–244 (2008).
Kyttaris, V.C. Kinase inhibitors: a new class of antirheumatic drugs. Drug. Des. Devel. Ther. 6, 245–250 (2012).
Dominguez, I., Sonenshein, G.E. & Seldin, D.C. CK2 and its role in Wnt and NF-kB signaling: linking development and cancer. Cell. Mol. Life Sci. 66, 1850–1857 (2009).
Trembley, J.H., Wang, G., Unger, G., Slaton, J. & Ahmed, K. Protein kinase CK2 in health and disease. Cell. Mol. Life Sci. 66, 1858–1867 (2009).
Seldin, D.C. et al. CK2 as a positive regulator of Wnt signalling and tumourigenesis. Mol. Cell. Biochem. 274, 63–67 (2005).
Buchou, T. et al. Disruption of the regulatory β subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol. Cell. Biol. 23, 908–915 (2003).
Wing, K. et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271–275 (2008).
Kashiwada, M. et al. IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching. Proc. Natl. Acad. Sci. USA 107, 821–826 (2010).
Ponce, D.P. et al. CK2 functionally interacts with AKT/PKB to promote the β-catenin-dependent expression of survivin and enhance cell survival. Mol. Cell. Biochem. 356, 127–132 (2011).
Song, D.H. CK2 Phosphorylation of the armadillo repeat region of β-catenin potentiates Wnt signaling. J. Biol. Chem. 278, 24018–24025 (2003).
Song, D.H. Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. J. Biol. Chem. 275, 23790–23797 (2000).
Ponce, D.P. et al. Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of β-catenin transcriptional activity. J. Cell. Physiol. 226, 1953–1959 (2011).
Larriba, M. et al. Vitamin D is a multilevel repressor of Wnt/β-catenin signaling in cancer cells. Cancers 5, 1242–1260 (2013).
Rochat, M.K. et al. Maternal vitamin D intake during pregnancy increases gene expression of ILT3 and ILT4 in cord blood. Clin. Exp. Allergy 40, 786–794 (2010).
Lu-Kuo, J.M., Joyal, D.M., Austen, K.F. & Katz, H.R. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. J. Biol. Chem. 274, 5791–5796 (1999).
Lorenz, U. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol. Rev. 228, 342–359 (2009).
Moran, A.E. et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 208, 1279–1289 (2011).
Sekiya, T. et al. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat. Immunol. 14, 230–237 (2013).
Gao, Y. et al. Control of T Helper 2 Responses by Transcription Factor IRF4-Dependent Dendritic Cells. Immunity 39, 722–732 (2013).
Williams, J.W. et al. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nat. Commun. 4, 2990 (2013).
Sakaguchi, S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531–562 (2004).
Xystrakis, E., Urry, Z. & Hawrylowicz, C.M. Regulatory T cell therapy as individualized medicine for asthma and allergy. Curr. Opin. Allergy Clin. Immunol. 7, 535–541 (2007).
Amsen, D. et al. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117, 515–526 (2004).
Amsen, D. et al. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 27, 89–99 (2007).
Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature 458, 351–356 (2009).
Josefowicz, S.Z. et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482, 395–399 (2012).
Gottschalk, R.A., Corse, E. & Allison, J.P. Expression of Helios in peripherally induced Foxp3+ regulatory T cells. J. Immunol. 188, 976–980 (2012).
Hori, S. Stability of regulatory T-cell lineage. Adv. Immunol. 112, 1–24 (2011).
Meggio, F. & Pinna, L.A. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17, 349–368 (2003).
Iype, T., Sankarshanan, M., Mauldin, I.S., Mullins, D.W. & Lorenz, U. The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells. J. Immunol. 185, 6115–6127 (2010).
Bottema, R.W.B. et al. Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE. Eur. Respir. J. 35, 54–63 (2009).
Cozza, G., Pinna, L.A. & Moro, S. Protein kinase CK2 inhibitors: a patent review. Expert Opin. Ther. Pat. 22, 1081–1097 (2012).
Lahl, K. et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204, 57–63 (2007).
Mittrücker, H.W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540–543 (1997).
Tuettenberg, A. et al. Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients. Int. J. Cancer 118, 2617–2627 (2006).
Muth, S., Schütze, K., Schild, H. & Probst, H.-C. Release of dendritic cells from cognate CD4+ T-cell recognition results in impaired peripheral tolerance and fatal cytotoxic T-cell mediated autoimmunity. Proc. Natl. Acad. Sci. USA 109, 9059–9064 (2012).
Ruedl, C., Rieser, C., Böck, G., Wick, G. & Wolf, H. Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches. Eur. J. Immunol. 26, 1801–1806 (1996).
Bopp, T. et al. NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+CD25+ regulatory T cells. J. Exp. Med. 201, 181–187 (2005).
Jonuleit, H. et al. Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells. J. Exp. Med. 196, 255–260 (2002).
Dehzad, N. et al. Regulatory T cells more effectively suppress Th1-induced airway inflammation compared with Th2. J. Immunol. 186, 2238–2244 (2011).
Diks, S.H. et al. Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J. Biol. Chem. 279, 49206–49213 (2004).
Staudt, V. et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192–202 (2010).
Powrie, F., Leach, M.W., Mauze, S., Caddle, L.B. & Coffman, R.L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5, 1461–1471 (1993).
Webster, K.E. et al. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206, 751–760 (2009).
Hartmann, W., Haben, I., Fleischer, B. & Breloer, M. Pathogenic nematodes suppress humoral responses to third-party antigens in vivo by IL-10-mediated interference with Th cell function. J. Immunol. 187, 4088–4099 (2011).